Repligen Corp. | Mutual Funds
Mutual Funds that own Repligen Corp.
iShares Core S&P Small Cap ETF
2,081,868
4.75%
588
0.24%
09/06/2018
Conestoga Small Cap Fund
1,232,300
2.81%
29,300
2.77%
07/31/2018
Oppenheimer International Small Company Fund
1,210,410
2.76%
0
0.63%
02/28/2018
Vanguard Total Stock Market Index Fund
985,951
2.25%
0
0.01%
07/31/2018
iShares Russell 2000 ETF
836,602
1.91%
-447
0.09%
09/06/2018
Delaware Small Cap Core Fund
740,400
1.69%
78,300
1.11%
05/31/2018
Fidelity Select Biotechnology Portfolio
701,286
1.6%
-18,400
0.42%
07/31/2018
iShares S&P Small Cap 600 Growth ETF
644,609
1.47%
925
0.49%
09/06/2018
Invesco Small Cap Growth Fund
595,168
1.36%
126,691
0.99%
06/29/2018
SPDR S&P Biotech ETF
551,663
1.26%
1,419
0.52%
09/06/2018
| Address |
41 Seyon Street
Waltham Massachusetts 02453
United States
|
|
Employees
|
- |
| Website |
http://www.repligen.com |
| Updated |
07/08/2019 |
| Repligen Corp. engages in the provision of bioprocessing technology and solutions. It operates through the following geographical segments: United States; Sweden; United Kingdom; and Other. It also serve through the following product lines: Protein; Filtration; Chromatography; and Other. |
